Outcomes for CLL Patients Treated with BTK inhibitor and BCL2 inhibitor - ASH 2021 CLL Society 4:21 1 year ago 86 Далее Скачать
Comparing BTK and BCL-2 inhibitor outcomes in different CLL subgroups VJHemOnc – Video Journal of Hematology & HemOnc 5:00 3 years ago 478 Далее Скачать
Outcomes of CLL patients following treatment with a covalent BTK and BCL2 inhibitor VJHemOnc – Video Journal of Hematology & HemOnc 1:19 2 years ago 102 Далее Скачать
Outcomes of CLL Patients After Treatment with BTK & BCL2 Inhibitors - EHA 2022 CLL Society 7:35 1 year ago 91 Далее Скачать
Treatment Options for CLL after Bruton’s Tyrosine Kinase Inhibitor and Venetoclax (BCL2i) - ASH 2021 CLL Society 12:40 1 year ago 152 Далее Скачать
Outcomes & healthcare utilization cost of patients with CLL refractory to BTK and BCL-2 inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 2:25 1 year ago 49 Далее Скачать
Combining BTK and BCL-2 inhibitors for the treatment of CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:26 2 years ago 131 Далее Скачать
BTK and BCL-2 inhibitor combination therapies in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:25 4 years ago 88 Далее Скачать
BTK and BCL2 inhibitor resistance in CLL: session highlights VJHemOnc – Video Journal of Hematology & HemOnc 3:12 2 years ago 134 Далее Скачать
The utility of MRD for predicting treatment outcomes in patients with CLL VJHemOnc – Video Journal of Hematology & HemOnc 1:36 2 years ago 192 Далее Скачать
Cardiovascular adverse events following treatment with BTK inhibitors in CLL & MCL VJHemOnc – Video Journal of Hematology & HemOnc 1:21 1 year ago 215 Далее Скачать
Understanding and overcoming resistance to BTK and BCL-2 inhibitors in CLL VJHemOnc – Video Journal of Hematology & HemOnc 2:12 1 year ago 127 Далее Скачать
Next-Generation BTK inhibitors and their role in the CLL treatment landscape VJHemOnc – Video Journal of Hematology & HemOnc 1:10 2 years ago 95 Далее Скачать
The impact of age and comorbidities on the outcomes of patients with CLL treated with BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 0:59 1 year ago 87 Далее Скачать
New Standards for CLL Care With BTK Inhibitors PeerView Oncology 1:36:53 3 years ago 411 Далее Скачать
Patient selection for BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:49 2 years ago 98 Далее Скачать
Treating patients with CLL who progress after BTK inhibitor therapy VJHemOnc – Video Journal of Hematology & HemOnc 2:22 3 years ago 422 Далее Скачать
Overview of Bruton's tyrosine kinase (BTK) inhibitors in chronic lymphocytic leukemia VJHemOnc – Video Journal of Hematology & HemOnc 2:46 8 years ago 1 906 Далее Скачать
Updates on non-covalent BTK inhibitors and their place in CLL treatment VJHemOnc – Video Journal of Hematology & HemOnc 2:58 2 years ago 236 Далее Скачать
